肝脏不同类型细胞衰老对肝纤维化发生发展的影响

郭珊; 阳学风

doi:10.3969/j.issn.1001-5256.2018.03.042

肝脏不同类型细胞衰老对肝纤维化发生发展的影响

DOI: 10.3969/j.issn.1001-5256.2018.03.042

郭珊,
阳学风

南华大学附属南华医院

基金项目:

国家自然科学基金资助项目(81373465)；

详细信息

中图分类号: R575.2
计量
- 文章访问数: 1799
- HTML全文浏览量: 25
- PDF下载量: 448
- 被引次数: 0
出版历程
- 出版日期: 2018-03-20

Influence of different types of cell senescence on the development and progression of liver fibrosis

Nanhua Hospital Affiliated to Nanhua University

Research funding:

摘要

摘要: 细胞衰老是细胞在受到某些特定刺激后而被激活的一种基本细胞应答程序,是生物机体的基本特征。肝纤维化是由各种致病因子所致肝内结缔组织异常增生,导致肝内弥漫性细胞外基质过度沉积的病理过程,可发展为肝硬化、肝癌。研究表明细胞衰老与肝纤维化的进展密切相关,针对肝内各种类型细胞衰老对肝纤维化的调控作用进行了综述。
- 肝硬化 /
- 细胞衰老 /
- 综述
Abstract: Cell senescence is a basic cell response triggered by various stimuli and is a basic characteristic of living organism. Liver fibrosis refers to the pathological process of diffuse excessive deposition of extracellular matrix in the liver caused by abnormal proliferation of connective tissue due to various pathogenic factors and can progress to liver cirrhosis and liver cancer. Studies have shown that cell senescence is closely associated with the progression of liver fibrosis. This article reviews the regulatory effect of different types of cell senescence on liver fibrosis.
- liver cirrhosis /
- cell aging /
- review

HTML全文

参考文献(44)

[1]ZHANG CY, YUAN WG, HE P, et al.Liver fibrosis and hepatic stellate cells:etiology, pathological hallmarks and therapeutic targets[J].World J Gastroenterol, 2016, 22 (48) :10512-10522.

[2]TSOCHATZIS EA, BOSCH J, BURROUGHS AK.Liver cirrhosis[J].Lancet, 2014, 383 (9930) :1749-1761.

[3]ZHANG J, WANG BY, SHI JP.Role of cell senescence in development and progression of nonalcoholic fatty liver disease[J].J Clin Hepatol, 2016, 32 (3) :442-445. (in Chinese) 张晶, 王炳元, 施军平.细胞衰老在非酒精性脂肪性肝病发生发展中的作用[J].临床肝胆病杂志, 2016, 32 (3) :442-445.

[4]HAYFLICK L, MOORHEAD PS.The serial cultivation of human diploid cell strains[J].Exp Cell Res, 1961, 25:585-621.

[5]WEISS CN, ITO K.DNA damage response, redox status and hematopoiesis[J].Blood Cells Mol Dis, 2014, 52 (1) :12-18.

[6]FUMAGALLI M, ROSSIELLO F, CLERICI M, et al.Telomeric DNA damage is irreparable and causes persistent DNA-damageresponse activation[J].Nat Cell Biol, 2012, 14 (4) :355-365.

[7]LOPEZ-OTIN C, BLASCO MA, PARTRIDGE L, et al.The hallmarks of aging[J].Cell, 2013, 153 (6) :1194-1217.

[8]LEE BY, HAN JA, IM JS, et al.Senescence-associated betagalactosidase is lysosomal beta-galactosidase[J].Aging Cell, 2006, 5 (2) :187-195.

[9]GIRE V, DULIC V.Senescence from G2 arrest, revisited[J].Cell Cycle, 2015, 14 (3) :297-304.

[10]COLLADO M, SERRANO M.Senescence in tumours:evidence from mice and humans[J].Nat Rev Cancer, 2010, 10 (1) :51-57.

[11]RUFINI A, TUCCI P, CELARDO I, et al.Senescence and aging:the critical roles of p53[J].Oncogene, 2013, 32 (43) :5129-5143.

[12]SMITH J, THO LM, XU N, et al.The ATM-Chk2 and ATRChk1 pathways in DNA damage signaling and cancer[J].Adv Cancer Res, 2010, 108 (4) :73-112.

[13]FERNANDEZ-CAPETILLO O, LEE A, NUSSENZWEIG M, et al.H2AX:the histone guardian of the genome[J].DNA Repair (Amst) , 2004, 3 (8-9) :959-967.

[14]BORODKINA A, SHATROVA A, ABUSHIK P, et al.Interaction between ROS dependent DNA damage, mitochondria and p38MAPK underlies senescence of human adult stem cells[J].Aging (Albany NY) , 2014, 6 (6) :481-495.

[15]LARSSON LG.Oncogene-and tumor suppressor gene-mediated suppression of cellular senescence[J].Semin Cancer Biol, 2011, 21 (6) :367-376.

[16]GUTIERREZ-REYES G, del CARMEN GARCIA de LEON M, VARELA-FASCINETTO G, et al.Cellular senescence in livers from children with end stage liver disease[J].PLo S One, 2010, 5 (4) :e10231.

[17]KIM WY, SHARPLESS NE.The regulation of INK4/ARF in cancer and aging[J].Cell, 2006, 127 (2) :265-275.

[18]BROOKES S, GAGRICA S, SANIJ E, et al.Evidence for a CDK4-dependent checkpoint in a conditional model of cellular senescence[J].Cell Cycle, 2015, 14 (8) :1164-1173.

[19]KARETA MS, GORGES LL, HAFEEZ S, et al.Inhibition of pluripotency networks by the Rb tumor suppressor restricts reprogramming and tumorigenesis[J].Cell Stem Cell, 2015, 16 (1) :39-50.

[20]KIM HW, SHIN JI, SEUNG BJ, et al.Differential and correlated expression of p16/p21/p27/p38 in mammary gland tumors of aged dogs[J].J Vet Sci, 2017.[Epub ahead of print]

[21]JIN H, LIAN N, ZHANG F, et al.Activation of PPARγ/P53 signaling is required for curcumin to induce hepatic stellate cell senescence[J].Cell Death Dis, 2016, 7:e2189.

[22]NISHIZAWA H, IGUCHI G, FUKUOKA H, et al.IGF-I induces senescence of hepatic stellate cells and limits fibrosis in a p53-dependent manner[J].Sci Rep, 2016, 6:34605.

[23]MANNAERTS I, SCHROYEN B, VERHULST S, et al.Gene expression profiling of early hepatic stellate cell activation reveals a role for Igfbp3 in cell migration[J].PLo S One, 2013, 8 (12) :e84071.

[24]SUMIDA Y, YONEI Y, TANAKA S, et al.Lower levels of insulin-like growth factor-1 standard deviation score are associated with histological severity of non-alcoholic fatty liver disease[J].Hepatol Res, 2015, 45 (7) :771-781.

[25]HANDAYANINGSIH AE, TAKAHASHI M, FUKUOKA H, et al.IGF-I enhances cellular senescence via the reactive oxygen species-p53 pathway[J].Biochem Biophys Res Commun, 2012, 425 (2) :478-484.

[26]HUBER S, GAGLIANI N, ZENEWICZ LA, et al.IL-22BP is regulated by the inflammasome and modulates tumorigenesis in the intestine[J].Nature, 2012, 491 (7423) :259-263.

[27]KONG X, FENG D, WANG H, et al.Interleukin-22 induces hepatic stellate cell senescence and restricts liver fibrosis in mice[J].Hepatology, 2012, 56 (3) :1150-1159.

[28]KOJIMA H, INOUE T, KUNIMOTO H, et al.IL-6-STAT3 signaling and premature senescence[J].JAKSTAT, 2013, 2 (4) :e25763.

[29]WANG H, LAFDIL F, KONG X, et al.Signal transducer and activator of transcription 3 in liver diseases:a novel therapeutic target[J].Int J Biol Sci, 2011, 7 (5) :536-550.

[30]KIRSCHNER K, CHANDRA T, KISELEV V, et al.Proliferation drives aging-related functional decline in a subpopulation of the hematopoietic stem cell compartment[J].Cell Rep, 2017, 19 (8) :1503-1511.

[31]NELSON G, WORDSWORTH J, WANG C, et al.A senescent cell bystander effect:senescence-induced senescence[J].Aging Cell, 2012, 11 (2) :345-349.

[32]VERMA S, TACHTATZIS P, PENRHYN-LOWE S, et al.Sustained telomere length in hepatocytes and cholangiocytes with increasing age in normal liver[J].Hepatology, 2012, 56 (4) :1510-1520.

[33]CARULLI L, ANZIVINO C.Telomere and telomerase in chronic liver disease and hepatocarcinoma[J].World J Gastroenterol, 2014, 20 (20) :6287-6292.

[34]WIEMANN SU, SATYANARAYANA A, TSAHURIDU M, et al.Hepatocyte telomere shortening and senescence are general markers of human liver cirrhosis[J].FASEB J, 2002, 16 (9) :935-942.

[35]ARAVINTHAN A, PIETROSI G, HOARE M, et al.Hepatocyte expression of the senescence marker p21 is linked to fibrosis and an adverse liver-related outcome in alcohol-related liver disease[J].PLo S One, 2013, 8 (9) :e72904.

[36]FAGGIOLI F, VEZZONI P, MONTAGNA C.Single-cell analysis of ploidy and centrosomes underscores the peculiarity of normal hepatocytes[J].PLo S One, 2011, 6 (10) :e26080.

[37]NAKANUMA Y, SATO Y, HARADA K.Tissue culture correlational study of genetic cholangiopathy of autosomal recessive polycystic kidney disease[J].Methods Mol Biol, 2013, 945 (2) :303-318.

[38]PINZANI M, LUONG TV.Pathogenesis of biliary fibrosis[J].Biochim Biophys Acta, 2017.[Epub ahead of print]

[39]TACKE F, WEISKIRCHEN R.Update on hepatic stellate cells:pathogenic role in liver fibrosis and novel isolation techniques[J].Expert Rev Gastroenterol Hepatol, 2012, 6 (1) :67-80.

[40]DING XM.MicroRNAs:regulators of cancer metastasis and epithelial-mesenchymal transition (EMT) [J].Chin J Cancer, 2014, 33 (3) :140-147.

[41]JIANG GX, ZHONG XY, CUI YF, et al.IL-6/STAT3/TFF3 signaling regulates human biliary epithelial cell migration and wound healing in vitro[J].Mol Biol Rep, 2010, 37 (8) :3813-3818.

[42]ANSIEAU S, BASTID J, DOREAU A, et al.Induction of EMT by twist proteins as a collateral effect of tumor-promoting inactivation of premature senescence[J].Cancer Cell, 2008, 14 (1) :79-89.

[43]SAGIV A, BIRAN A, YON M, et al.Granule exocytosis mediates immune surveillance of senescent cells[J].Oncogene, 2013, 32 (15) :1971-1977.

[44]ZHOU Y.The regulation of CD4+T cell senescence by miR-181a and its signaling pathway in HCV infected patients[D].Xi'an:The Fourth Mil Med Univ, 2015. (in Chinese) 周云.丙型肝炎病毒感染者miR-181a对CD4+T细胞衰老的调节作用及信号传导[D].第四军医大学, 2015.

施引文献

资源附件(0)

访问统计